Systematic Review of Otologic Adverse Events in Hyperbaric Oxygen Therapy
Systematische Übersicht otologischer unerwünschter Ereignisse bei Hyperbare-Oxygen-Therapie
Undersea and Hyperbaric Medicine · 24.11.2025 · 52 (4) · 537-547
DOI: 10.22462/736 ↗Auf einen Blick
Die systematische Übersicht zeigte: 15 % der 18.284 mit HBO2 behandelten Patient:innen erlitten otologische unerwünschte Ereignisse. Zu den Risikofaktoren zählten höheres Alter, weibliches Geschlecht und Vorerkrankungen im Kopf-Hals- bzw. neurologischen Bereich.
Fragestellung
Welche otologischen Komplikationen sind mit HBO2-Therapie verbunden, und welche Risiko- bzw. Schutzfaktoren gibt es?
Methode
Systematische Übersicht nach PRISMA 2020; 2.027 Treffer gescreent, 183 relevant, 54 Studien eingeschlossen.
Ergebnisse
15 % der 18.284 Patient:innen hatten adverse events. Beim Mittelohr-Barotrauma waren 42,8 % mild und 6,4 % schwer. Hauptrisikofaktoren: höheres Alter, weibliches Geschlecht, Kopf-Hals-Pathologie, sensible Neuropathie, Probleme beim Druckausgleich.
Schlussfolgerung der Autor:innen
15 % der Patient:innen entwickelten otologische Komplikationen durch HBO2. Älteres Alter, weibliches Geschlecht und Kopf-Hals- oder neurologische Vorerkrankungen könnten das Risiko für MEB erhöhen.
Kernaussagen
- 15 % der 18.284 Patient:innen hatten otologische adverse events
- MEB war zu 42,8 % mild und zu 6,4 % schwer
- Effektive Druckausgleichstechniken wirkten als Schutzfaktor
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Undersea and Hyperbaric Medicine, online erschienen am 24.11.2025. Verfasst von Andrew Voigt und 9 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Patientensicherheit
Abstract (Originalsprache)
Voigt A, Laspro M, Thys E, Jethanamest D, Chiu ES. Systematic Review of Otologic Adverse Events in Hyperbaric Oxygen Therapy. Undersea Hyperb Med. 2025 Fourth Quarter; 52(4):537-547.
Objectives
Hyperbaric Oxygen (HBO2) Therapy has been associated with some risks and adverse events. Previous studies examining otologic complications from HBO2 therapy vary in their reported incidence of adverse events. This study aims to systematically review the otologic complications associated with HBO2 therapy and investigate contributing risk and protective factors. Review Methods: A systematic review was conducted to identify studies reporting otologic adverse effects due to HBO2 therapy. Utilizing PRISMA 2020 guidelines, titles and abstracts were screened before conducting a full-text analysis. Studies reporting the incidence of otologic complications and studies reporting risk or protective factors for otologic complications were included.
Results
A search for articles on HBO2 therapy otologic complications yielded 2,027 articles, of which 183 were relevant to the research question. Ultimately, 54 studies met the inclusion criteria. Fifteen percent of the 18,284 patients treated with HBO2 therapy experienced adverse events. Of the middle ear barotrauma (MEB) that occurred, 42.8% was mild, and 6.4% was severe. The major risk factors were increasing age, female sex, head and neck pathology, sensory neuropathy, and pre-treatment difficulty equalizing ear pressure. The main protective factor was experience with effective equalization techniques.
Conclusions
15% of patients experienced otologic complications due to HBO2 therapy. Older age, female sex, and a history of head and neck or neurological conditions may increase the risk for MEB. Increased monitoring of higher-risk patients during initial treatment sessions and proper equalization techniques may help prevent MEB during HBO2 therapy. This is the most comprehensive systematic review on the topic to date. Keywords: complications; hyperbaric oxygen therapy; middle ear barotrauma; otologic adverse events
Zitieren
APA
Voigt, A., MD, Laspro, M., MD, Thys, E., MD, Jethanamest, D., MD, Chiu, E., & MD (2025). Systematic Review of Otologic Adverse Events in Hyperbaric Oxygen Therapy. Undersea and Hyperbaric Medicine, 52(4), 537-547. https://doi.org/10.22462/736
Vancouver
Voigt A, MD, Laspro M, MD, Thys E, MD, et al. Systematic Review of Otologic Adverse Events in Hyperbaric Oxygen Therapy. Undersea and Hyperbaric Medicine. 2025;52(4):537-547. doi:10.22462/736
BibTeX
@article{Voigt2025,
author = {Voigt, Andrew and MD and Laspro, Matteo and MD and Thys, Erika and MD and Jethanamest, Daniel and MD and Chiu, Ernest and MD},
title = {Systematic Review of Otologic Adverse Events in Hyperbaric Oxygen Therapy},
journal = {Undersea and Hyperbaric Medicine},
year = {2025},
volume = {52},
number = {4},
pages = {537--547},
doi = {10.22462/736}
}
EUVIMED